NCT04196686

Brief Summary

The purpose of this study is to evaluate the effectiveness of different technologies, Virtual Reality and Augmented Reality with modifications as passive content, active content, cognitive load modulation, and positive encouragement coaching to increase the pain threshold as assessed by immersing a hand in ice water.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
185

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 24, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 19, 2019

Completed
23 days until next milestone

First Posted

Study publicly available on registry

December 12, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 4, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 4, 2021

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

March 25, 2022

Completed
Last Updated

March 25, 2022

Status Verified

February 1, 2022

Enrollment Period

1.6 years

First QC Date

November 19, 2019

Results QC Date

February 28, 2022

Last Update Submit

February 28, 2022

Conditions

Keywords

Virtual RealityAugmented RealityIce Immersion

Outcome Measures

Primary Outcomes (1)

  • VR Effect on Pain Tolerence

    Given that the cold pressor test produces an uncomfortable experience, we considered longer duration within the ice bath to represent increased pain tolerance. Measured in seconds (s).

    Duration of ice bath (approximately 0 - 4 minutes)

Secondary Outcomes (2)

  • VR's Effect on Perceived Pain Intensity

    Duration of ice bath (approximately 0 - 4 minutes)

  • Skin Conductance Response Density (SCRD)

    Duration of ice bath (approximately 0 - 4 minutes)

Study Arms (2)

Ice bath Control then VR/AR

EXPERIMENTAL

Participants will be randomized with a 1:1 allocation to use their dominant or non-dominant hand with VR or control (no VR) for the cold pressor test and then crossed over. Participants will not be told of the specifics of the time limit, to avoid competitiveness and expectations and will be asked for pain scores every 30 seconds.

Device: VR/AROther: Ice Bath

Ice bath with VR/AR then Control

EXPERIMENTAL

Participants will be randomized with a 1:1 allocation to use their dominant or non-dominant hand with VR or control (no VR) for the cold pressor test and then crossed over. Participants will not be told of the specifics of the time limit, to avoid competitiveness and expectations and will be asked for pain scores every 30 seconds.

Device: VR/AROther: Ice Bath

Interventions

VR/ARDEVICE

VR/AR headset with either passive or active content such as playing a game or watching a movie

Ice bath Control then VR/ARIce bath with VR/AR then Control

Participants immerse hand in ice bath and starting again with their original assigned group and keep hand submerged as long as they can withstand the cold or until 4 minutes have elapsed, whichever comes first. Participants will not be told of the specifics of the time limit, to avoid competitiveness and expectations and will be asked for pain scores every 30 seconds.

Ice bath Control then VR/ARIce bath with VR/AR then Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Greater than 18 years of age
  • English speaking
  • Hearing intact

You may not qualify if:

  • Patients who do not consent
  • Currently taking beta blockers or other chronotropic heart medication(s)
  • Have a history of severe motion sickness
  • Currently have nausea
  • Currently experiencing seizures
  • Are clinically unstable
  • Have taken pain medications in the last 12 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

NeuralgiaAcute Pain

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Samuel Rodriguez, MD
Organization
Lucile Packard Children's Hospital Stanford

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

November 19, 2019

First Posted

December 12, 2019

Study Start

July 24, 2019

Primary Completion

March 4, 2021

Study Completion

March 4, 2021

Last Updated

March 25, 2022

Results First Posted

March 25, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations